These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9153427)

  • 1. 17 alpha (haloacetamidoalkyl) estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530.
    Aliau S; El Garrouj D; Yasri A; Katzenellenbogen BS; Borgna JL
    Biochemistry; 1997 May; 36(19):5861-7. PubMed ID: 9153427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
    Aliau S; Mattras H; Richard E; Borgna JL
    Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
    Reese JC; Katzenellenbogen BS
    J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: roles in ligand binding and transcriptional activation.
    Reese JC; Wooge CH; Katzenellenbogen BS
    Mol Endocrinol; 1992 Dec; 6(12):2160-6. PubMed ID: 1491695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain.
    Aliau S; Mattras H; Borgna JL
    J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):111-21. PubMed ID: 16439113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution.
    Neff S; Sadowski C; Miksicek RJ
    Mol Endocrinol; 1994 Sep; 8(9):1215-23. PubMed ID: 7838154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidal affinity labels of the estrogen receptor. 2. 17 alpha-[(Haloacetamido)alkyl]estradiols.
    el Garrouj D; Aliau S; Aumelas A; Borgna JL
    J Med Chem; 1995 Jun; 38(13):2339-48. PubMed ID: 7608900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
    Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
    Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal affinity labels of the estrogen receptor alpha. 4. Electrophilic 11beta-aryl derivatives of estradiol.
    Aliau S; Delettre G; Mattras H; El Garrouj D; Nique F; Teutsch G; Borgna JL
    J Med Chem; 2000 Feb; 43(4):613-28. PubMed ID: 10691688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
    Hurth KM; Nilges MJ; Carlson KE; Tamrazi A; Belford RL; Katzenellenbogen JA
    Biochemistry; 2004 Feb; 43(7):1891-907. PubMed ID: 14967030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin decreases the estrogen binding capacity of the estrogen receptor.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1996 Oct; 227(3):651-7. PubMed ID: 8885989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
    Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
    Martin SS; Holleran BJ; Escher E; Guillemette G; Leduc R
    Mol Pharmacol; 2007 Jul; 72(1):182-90. PubMed ID: 17446269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
    Harlow KW; Smith DN; Katzenellenbogen JA; Greene GL; Katzenellenbogen BS
    J Biol Chem; 1989 Oct; 264(29):17476-85. PubMed ID: 2793867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
    Ehrlich GK; Andria ML; Zheng X; Kieffer B; Gioannini TL; Hiller JM; Rosenkranz JE; Veksler BM; Zukin RS; Simon EJ
    Can J Physiol Pharmacol; 1998 Mar; 76(3):269-77. PubMed ID: 9673790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
    Deng HB; Guang W; Wang JB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
    Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
    Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
    Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.